Related Experiment Video
Updated: May 15, 2025

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
Published on: August 20, 2019
The RaDiCo information system for rare disease cohorts
Paul Landais1, Sonia Gueguen2, Annick Clement3
1Childhood Genetic Diseases Laboratory, Université de Montpellier, Inserm U933, 26 rue Arnold Netter, 75012, Montpellier, France. paul.landais@umontpellier.fr.
The RaDiCo platform offers a national infrastructure for rare disease (RD) e-cohorts, improving data quality and accessibility. This secure system supports the creation, monitoring, and analysis of RDs, benefiting patients and researchers.
Area of Science:
- Medical Informatics
- Genomics
- Epidemiology
Background:
- Rare diseases (RDs) present significant challenges in clinical care and research due to patient dispersion and limited data resources.
- Existing databases are often local, small, incomplete, and lack standardization, hindering interoperability and interdisciplinary cooperation.
- There is a critical need for a coordinated, secure, and interoperable framework to generate high-quality deep phenotyping and molecular data from RD cohorts.
Purpose of the Study:
- To present the Information System (IS) of the RaDiCo program, a national operational platform for developing rare disease e-cohorts.
- To establish a coordinated, mutualized, secure, and interoperable framework for generating high-quality RD data.
- To facilitate the creation and management of national RD e-cohorts.
Main Methods:
- The RaDiCo platform is cloud-based, promoting process and service mutualization for clinical epidemiology and IS.
- Its IS incorporates an interoperability framework with unique RD identifiers, data standardization, FAIR principles, secure data exchange, and GDPR compliance.
- A secure, open-source web application enables online database management and patient data collection.
Main Results:
- The RaDiCo IS is efficient, currently hosting 13 e-cohorts covering 67 distinct rare diseases.
- As of April 2024, 8063 patients have been recruited from 180 specialized RD sites across France.
- The system ensures continuous monitoring of data quality and consistency.
Conclusions:
- RaDiCo functions as a national infrastructure for developing rare disease e-cohorts without size or number limitations.
- The IS is GDPR-compliant, compatible with the French National Health Data Hub, and extendable to European Reference Networks (ERNs) for rare diseases.
- RaDiCo provides a robust platform for the creation, monitoring, and analysis of rare disease e-cohorts.
Related Concept Videos
Statistical Software for Data Analysis and Clinical Trials
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...

